Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Familial Primary Biliary Cirrhosis in Sisters

Jin SY

  • KMID: 760533
  • Korean J Hepatol.
  • 2004 Mar;10(1):73-77.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Introduction of Bioinformatic Methods for the Gene Function Analysis

Kim SS

  • KMID: 760527
  • Korean J Hepatol.
  • 2004 Mar;10(1):11-21.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Arterioportal Shunt Mimicking Hepatocellular Carcinoma

Han JK, Kim SH

  • KMID: 760534
  • Korean J Hepatol.
  • 2004 Mar;10(1):78-80.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Strategy for YMDD Mutants of Hepatitis B Virus

Ryu SH, Chung YH

  • KMID: 760526
  • Korean J Hepatol.
  • 2004 Mar;10(1):1-10.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genotypes of Hepatitis B Virus on Jeju Island

Cho JH, Park DS, Kim TH, Yeom JJ, Kim HC, Moon JH, Yang JS

  • KMID: 760530
  • Korean J Hepatol.
  • 2004 Mar;10(1):42-50.
BACKGROUND/AIMS: Hepatitis B virus (HBV) was classified into 8 genotypes by a sequence divergence in the entire genome designated from A to H. HBV genotypes have distinct geographic distributions....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pretreatment ALT Level and Histologic Activity as Predictors of HBeAg Loss in Lamivudine Treatment for Chronic Hepatitis B

Kweon YO, Kang KH

  • KMID: 760529
  • Korean J Hepatol.
  • 2004 Mar;10(1):31-41.
BACKGROUND/AIMS: Lamivudine is a potent inhibitor of hepatitis B virus replication, but an increased incidence of YMDD mutation may be associated with its long term use. Thus, the decision...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adequacy of Immediate Lamivudine Trial for Chronic Hepatitis B Patients with Acute Exacerbation

Lee CK, Suh JH, Cho YS, Won SY, Park IS

  • KMID: 760528
  • Korean J Hepatol.
  • 2004 Mar;10(1):22-30.
BACKGROUND/AIMS: It has been unclear whether immediate antiviral therapy or observation under the expectation of spontaneous inactivation of hepatitis B virus (HBV), is more appropriate for the treatment of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Angiostatin, Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9 and 12 in the Angiogenesis of Hepatocellular Carcinoma

Kim S, Park HS, Son HJ, Moon WS

  • KMID: 760532
  • Korean J Hepatol.
  • 2004 Mar;10(1):62-72.
BACKGROUND/AIMS: Tumor angiogenesis, a major requirement for tumor growth and metastasis, is regulated by pro- and anti-angiogenic factors. Hepatocellular carcinoma (HCC) has become a common malignant tumor worldwide. It...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Factors of Morbidity and Mortality Following Surgical Resection for Hepatocellular Carcinoma

Kim WW, Lee KW, Choi SH, Heo JS, Kim YI, Kim SJ, Lee DS, Lee HH, Paik SW, Koh KC, Lee JH, Choi MS, Yoo BC, Joh JW

  • KMID: 760531
  • Korean J Hepatol.
  • 2004 Mar;10(1):51-61.
BACKGROUND/AIMS: Recently, mortality following surgical resection for hepatocelluar carcinoma has been reduced significantly. Morbidity, however, is still significant. This study evaluated the risk factors leading to morbidity and mortality. ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr